Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ThromboGenics begins patient enrolment for Phase II trial of THR-317 to treat diabetic macular edema

Go Top